Regulation & policy

NAD flags Bayer One A Day men’s fertility positioning

NAD flags Bayer One A Day men’s fertility positioning

By Cassandra Stern

The National Advertising Division (NAD) has recommended that Bayer HealthCare LLC discontinue or modify a series of claims tied to its One A Day Men’s Pre-Conception Health Complete Multivitamin, concluding that product positioning and messaging conveyed...

Is FDA opening the long‑shut DSHEA ‘innovation door’?

Is FDA opening the long‑shut DSHEA ‘innovation door’?

By Stephen Daniells

The upcoming public Food and Drug Administration (FDA) meeting exploring the scope of dietary supplement ingredients will revisit one of the most contested and, according to DSHEA’s architects, most misunderstood phrases in the U.S. dietary supplement law.

New bill aims to end patchwork of state supplement regulations

New bill aims to end patchwork of state supplement regulations

By Cassandra Stern

A Republican congressman has introduced legislation seeking to reaffirm federal oversight of dietary supplements, blocking states from imposing their own additional regulatory requirements and creating what he characterized as a “confusing patchwork of...

Cara Welch outlines strategic priorities for supplement oversight

Cara Welch outlines strategic priorities for supplement oversight

By Asia Sherman

Following the release of the Human Food Program 2026 Deliverables last week, the Food and Drug Administration’s Office of Dietary Supplement Programs (ODSP) is communicating its priorities for dietary supplement oversight in the year to come.

Why a dietary supplement registry is pro-MAHA, pro-consumer and pro-industry

Guest article

Why a dietary supplement registry is pro-MAHA, pro-consumer and pro-industry

By Steve Mister, President & CEO, CRN

In a recent column, Daniel Fabricant of the Natural Products Association argues that mandatory product listing (MPL) is anti-MAHA, anti-innovation and a threat to the regulatory balance established by DSHEA. But that argument rests on a false premise:...

Functional Mushroom Council launched amid market growth

Functional Mushroom Council launched amid market growth

By Cassandra Stern

The Functional Mushroom Council (FMC) has launched as a nonprofit industry organization representing North American functional mushroom growers, suppliers and brands, with a focus on research, education and quality standards.

ANH-USA sues FDA over nutrient–disease claims rejection

ANH-USA sues FDA over nutrient–disease claims rejection

By Stephen Daniells

The Alliance for Natural Health USA (ANH-USA) has filed a federal lawsuit against the U.S. Food and Drug Administration (FDA) over the agency’s recent rejection of a petition to allow over 110 ‘government-backed’ disease risk reduction health claims.

Senator Durbin’s mandatory listing proposal is anti-MAHA—not pro-health

Guest article

Senator Durbin’s mandatory listing proposal is anti-MAHA—not pro-health

By Daniel Fabricant, PhD, president and CEO, Natural Products Association

The Make America Healthy Again (MAHA) movement is built on a simple but powerful promise. Our government should expand access to preventive and wellness tools and reject one-size-fits-all bureaucratic solutions that treat citizens as incapable of making...

Sen. Durbin reintroduces Dietary Supplement Listing Act again

Sen. Durbin reintroduces Dietary Supplement Listing Act again

By Asia Sherman

U.S. Senate Democratic Whip Richard Durbin (D-IL) has introduced the Dietary Supplement Listing Act of 2026, which would require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA).

NutraCast: The hidden epidemic of unapproved research peptides

NutraCast: The hidden epidemic of unapproved research peptides

By Danielle Masterson

Banned Substances Control Group’s Oliver Catlin recently partnered with the Associated Press to expose something shocking: research peptides marketed as “laboratory chemicals” are flooding mainstream platforms like Amazon and Alibaba.

Trump executive order targets hemp-derived CBD regulation

Trump executive order targets hemp-derived CBD regulation

By Cassandra Stern

The Trump Administration issued an executive order today directing federal agencies to finalize the rescheduling of marijuana to Schedule III and to develop a new regulatory framework for hemp-derived cannabinoid products, including CBD.

A year of growth and tending to the garden: Looking ahead for dietary supplements

Guest article

A year of growth and tending to the garden: Looking ahead for dietary supplements

By Graham Rigby, President & CEO, American Herbal Products Association

As the American Herbal Products Association (AHPA) readies for the new year, we pause to reflect on a period of profound change and robust growth, navigating an increasingly complex landscape of regulation, market trends and policy shifts. This year, we...

Editors’ picks: Our favorite articles of 2025

Editors’ picks: Our favorite articles of 2025

We enjoy writing some articles more than others, whether it’s because of the subject, the impact for industry, the insights from commentators or other reasons. But which articles did we enjoy writing the most and why?